VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
MTEXMannatech, Incorporated
$5.40$10M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksMTEXP/E History

MTEX logoMannatech, Incorporated (MTEX) P/E Ratio History

Deep Value

Trading at -0.7x · 0th percentile of 5-year range · Significant discount to historical valuation · Data 1999–2024

Current P/E (TTM)
-0.7x
-104% vs 5Y avg
5Y Avg P/E
17.1x
Median 8.9x
5Y Percentile
0th
Lower end of range
PEG Ratio
N/A
5-Year P/E Range
-0.7x
Min4.9xMedian8.9xMax67.8x
TTM EPS$-6.59
Price$5.40
Earnings YieldN/A
EPS Growth (1Y)-706.1%
EPS Growth (5Y)N/A

Loading P/E history...

P/E Ratio Analysis

As of June 23, 2026, Mannatech, Incorporated (MTEX) trades at a price-to-earnings ratio of -0.7x, with a stock price of $5.40 and trailing twelve-month earnings per share of $-6.59.

The current P/E is 104% below its 5-year average of 17.1x. Over the past five years, MTEX's P/E has ranged from a low of 4.9x to a high of 67.8x, placing the current valuation at the 0th percentile of its historical range.

Compared to the Consumer Defensive sector median P/E of 18.7x, MTEX trades at a 104% discount to its sector peers. The sector includes 151 companies with P/E ratios ranging from 0.0x to 193.7x.

Relative to the broader market, MTEX trades at a notable discount to the S&P 500 median P/E of 24.3x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our MTEX DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

MTEX Cross-Benchmark Valuation

How does the current P/E compare to sector peers and the broader market?

vs. Consumer Defensive
-0.7vs18.7
-104%
Below Sector
vs. S&P 500
-0.7vs24.3
-103%
Below Market
PEG Analysis
N/A
P/E ÷ EPS Growth
Based on -706% EPS growth (1Y)

MTEX P/E vs Peers

Beauty Services and Direct Selling peers sorted by market cap

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
NATR logoNATRNature's Sunshine Products, Inc.
$359M19.2-+165%
LFVN logoLFVNLifeVantage Corporation
$77M8.0-+230%Best
USNA logoUSNAUSANA Health Sciences, Inc.
$349M32.6--74%
HLF logoHLFHerbalife Nutrition Ltd.
$1B5.5--12%
NUS logoNUSNu Skin Enterprises, Inc.
$243M1.6Lowest-+208%
QNST logoQNSTQuinStreet, Inc.
$746M161.0-+114%
AMZN logoAMZNAmazon.com, Inc.
$2.5T32.51.22Best+30%

Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.

MTEX Historical P/E Data (1999–2024)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterPeriod EndPriceTTM EPSP/E Ratiovs Avg
FY2024 Q4-$13.43$1.3310.1x-76%
FY2022 Q3Sep 30 2022$20.80$2.269.2x-79%
FY2022 Q2-$16.50$3.095.3x-88%
FY2022 Q1-$36.34$3.749.7x-77%
FY2021 Q4Dec 31 2021$38.32$4.728.1x-81%
FY2021 Q3-$32.68$3.818.6x-80%
FY2021 Q2Jun 30 2021$27.71$3.138.9x-79%
FY2021 Q1Mar 31 2021$20.38$2.617.8x-82%
FY2020 Q4-$18.60$2.726.8x-84%
FY2020 Q3Sep 30 2020$16.75$3.255.2x-88%
FY2020 Q2-$14.80$1.877.9x-82%
FY2020 Q1-$10.78$2.214.9x-89%
FY2019 Q4-$16.09$1.3412.0x-72%
FY2017 Q3Sep 30 2017$14.50$0.2753.7x+25%
FY2017 Q2Jun 30 2017$15.60$0.2367.8x+58%
FY2016 Q3Sep 30 2016$17.97$0.7524.0x-44%
FY2016 Q2-$20.24$0.3263.3x+47%
FY2016 Q1-$23.50$1.9612.0x-72%
FY2015 Q4-$18.85$2.158.8x-80%
FY2015 Q3Sep 30 2015$18.96$2.278.4x-81%
FY2015 Q2-$18.00$4.134.4x-90%
FY2015 Q1-$18.76$2.726.9x-84%
FY2014 Q4Dec 31 2014$26.65$2.4011.1x-74%
FY2014 Q3-$15.59$2.675.8x-86%
FY2014 Q2Jun 30 2014$12.14$0.4825.3x-41%
FY2014 Q1Mar 31 2014$17.31$1.0416.6x-61%
FY2013 Q4-$16.96$1.2014.1x-67%
FY2013 Q3Sep 30 2013$24.03$0.3470.7x+65%
FY2013 Q2Jun 30 2013$11.09$1.477.5x-82%
FY2013 Q1Mar 31 2013$6.39$0.2426.6x-38%
FY2007 Q4Dec 31 2007$63.20$2.5524.8x-42%
FY2007 Q3Sep 30 2007$81.00$7.0011.6x-73%
FY2007 Q2Jun 30 2007$158.90$9.9016.1x-63%
FY2007 Q1Mar 31 2007$160.60$12.4013.0x-70%
FY2006 Q4Dec 31 2006$147.30$12.0012.3x-71%
FY2006 Q3Sep 30 2006$177.20$12.4314.3x-67%
FY2006 Q2Jun 30 2006$126.10$12.0310.5x-76%
FY2006 Q1Mar 31 2006$173.80$11.0315.8x-63%
FY2005 Q4Dec 31 2005$138.10$10.5313.1x-69%
FY2005 Q3Sep 30 2005$118.50$8.4914.0x-67%
FY2005 Q2-$190.20$7.7924.4x-43%
FY2005 Q1-$195.50$7.6925.4x-41%
FY2004 Q4Dec 31 2004$190.40$7.0926.9x-37%
FY2004 Q3-$140.20$6.8620.4x-52%
FY2004 Q2Jun 30 2004$96.00$5.4617.6x-59%
FY2004 Q1Mar 31 2004$105.80$3.8627.4x-36%
FY2003 Q4Dec 31 2003$108.90$3.3632.4x-24%
FY2003 Q3-$54.60$2.4322.5x-48%
FY2003 Q2Jun 30 2003$74.70$1.4352.2x+22%
FY2003 Q1Mar 31 2003$25.30$1.1322.4x-48%
FY2002 Q4-$16.20$0.7322.2x-48%
FY2002 Q3Sep 30 2002$13.50$0.011350.0x+3047%
FY2000 Q2Jun 30 2000$23.13$1.7713.1x-70%
FY2000 Q1Mar 31 2000$37.50$2.8113.3x-69%
FY1999 Q4Dec 31 1999$51.88$4.2112.3x-71%

Average P/E for displayed period: 42.9x

Export Data
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

27+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

MTEX — Frequently Asked Questions

Quick answers to the most common questions about buying MTEX stock.

What is MTEX's P/E ratio?

Mannatech, Incorporated (MTEX) trailing twelve-month P/E ratio is -0.7x, based on TTM diluted EPS of $-6.59. The 5-year average P/E is 17.1x and the historical range spans 4.9x to 67.8x.

Is MTEX stock overvalued or undervalued?

MTEX trades at -0.7x P/E, below its 5-year average of 17.1x. At the 0th percentile of its historical range (4.9x–67.8x), the stock is priced at a discount to its own history.

Is MTEX stock expensive?

No, MTEX is not expensive on a historical basis. The current P/E of -0.7x is below the 5-year average of 17.1x and sits at the 0th percentile of its valuation range.

What is MTEX's historical P/E range?

Over the past 5 years, MTEX's P/E ratio has ranged from 4.9x to 67.8x, with a median of 8.9x and an average of 17.1x. The current P/E of -0.7x places the stock at the 0th percentile of this range. Full historical data spans 1999–2024.

How does MTEX's P/E compare to the S&P 500?

MTEX trades at -0.7x P/E versus the S&P 500 median of 24.3x. The 103% discount to the market suggests lower growth expectations or perceived higher risk.

How does MTEX's valuation compare to Consumer Defensive peers?

Mannatech, Incorporated P/E of -0.7x compares to the Consumer Defensive sector median of 18.7x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.

What is MTEX's PEG ratio?

MTEX PEG ratio is N/A, based on a P/E of -0.7x and EPS growth of -706.1%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.

What is MTEX's earnings yield?

MTEX earnings yield is N/A, the inverse of its -0.7x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.

MTEX P/E Ratio History (1999–2024)

Quarterly valuation multiple from closing price and trailing EPS

Current10.1x
Period Avg17.1x
Range4.9x - 67.8x
Change+21%
20 quartersSep 30, 2015 - Dec 31, 2024